About Us
Leardership
Kreps Robert
Mr. Robert is an accomplished pharmaceutical executive and clinical pharmacologist with over a decade of experience leading drug development programs in a variety of disease areas. After joining freaky Med as Chief Development Officer in January 2021, he was named CEO in June 2021
Julia Tuckson
Ms. Julia began her career as a molecular biologist, transitioning to a career in Regulatory Affairs for Wyeth Vaccines, Johnson & Johnson Pharmaceutical Research Division, and Novartis Pharmaceuticals Corporation.
Roger Barrow
Roger joined MindMed as Vice President, Head of Development in May 2022. Rob holds senior leadership positions at Freaky Med Store Pharmaceuticals and Ipsen Bioscience, leading global drug development teams focused on psychiatry and neurology indications and working to advance new treatments for difficult to treat disorders.
Bridgit Makes
Bridgit is Board Certified in Psychiatry, Addiction Medicine, and Clinical Informatics. She is an Assistant Professor of Psychiatry at Tufts University School of Medicine. She graduated with degrees in Neuroscience and Behavior (BA), and Clinical Informatics (MA), Columbia University; Medicine (MD), University of Colorado School of Medicine..